Life Time's Oct. 25 nationwide fundraiser for ALS research challenges participants to work out for 90 minutes.

It took time for Philip to discover acceptance was key to him for living with ALS. Learn about his journey from diagnosis to ...

Although the exact causes of ALS remain unknown, both genetic and environmental factors may contribute to its development.

A Phase 3 clinical trial testing pridopidine in people with ALS is expected to start enrolling patients in January.

An AI model used seven common clinical measures of inflammation, nutritional status, and more to predict ALS prognosis, a ...

Advocates in Canada are urging their federal government to invest more in ALS research and trial opportunities.

Building an online store has given columnist Kristin Neva and her husband, Todd, a project to work on together.

A pivotal Phase 3 clinical trial testing the oral therapy pridopidine in people with amyotrophic lateral sclerosis (ALS) is expected to start in January, following promising results seen in the HEALEY ...